Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Pioneering diagnostics in dermatology and cancer

Project description

Innovative technological platform for modern dermatology diagnostics

Conventional dermatology diagnostics involve visual clinical observation and histopathology that are often imprecise and subjective, resulting in a high rate of misdiagnosed cases and insufficient therapies. The EU-funded Dermagnostix project aims to develop modern molecular diagnostics to improve patients’ treatment and clinical practice in dermatology. Dermagnostix has developed a comprehensive technological platform for fast and objective molecular dermatology diagnostics to improve treatment while reducing healthcare costs. The fully automated platform delivers results within 90 minutes as objective and precise skin diagnostics, including up to 40 different molecular targets within one single test. The current project will enable the development of new tests for the area of skin cancer and chronic inflammatory skin diseases.

Objective

At Dermagnostix, we envision the next level for molecular diagnostics in human skin to improve patients’ lives and clinical practice in dermatology.
Skin diseases are the 4th most relevant human illnesses according to loss of quality of life. Conventional diagnostics in dermatology based on clinical view and histopathology are imprecise and subjective, resulting in up to 50% of misdiagnosed cases and insufficient or harmful therapies.
At Dermagnostix, we have developed a comprehensive technological platform for fast and objective molecular diagnostics in dermatology to reduce health care costs and improve patient treatment. Our fully automated platform delivers results within 90 min and testing can be run everywhere and at any time. Our easy-to-handle diagnostic device brings objective and precise skin diagnostics to reality allowing simultaneous detection of up to 40 different molecular targets within one single test.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2022-ACCELERATOR-01

See all projects funded under this call

Coordinator

DERMAGNOSTIX GMBH
Net EU contribution
€ 2 499 000,00
Address
GEORGES-KOHLER-ALLEE 302
79110 Friedberg
Germany
SME
Yes
Region
Bayern Schwaben Aichach-Friedberg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 5 169 182,50